Nektar Therapeutics (NKTR) Treasury Shares (2010 - 2025)

Nektar Therapeutics' Treasury Shares history runs 14 years deep, the most recent figure standing at $552307.0 for Q2 2025.

• On a quarterly basis, Treasury Shares changed 0.0% year-over-year to $3.0 million in Q2 2025; TTM through Jun 2025 was $3.0 million, a 0.0% change from a year earlier, with the FY2024 full-year figure at $3.0 million, changed N/A from the prior year.
• Treasury Shares was little changed at $3.0 million in Q2 2025 per NKTR's latest filing, from $3.0 million in the prior quarter.
• Across five years, Treasury Shares topped out at $3.0 million in Q1 2024 and bottomed at $3.0 million in Q1 2024.
• The 5-year median for Treasury Shares is $552307.0 (2024), against an average of $3.0 million.
• Across the five-year window, Treasury Shares soared 39.98% in 2021 and plunged 86.94% in 2024, its largest moves.
• Year by year, Treasury Shares stood at $3.0 million in 2024, then changed by 0.0% to $3.0 million in 2025.
• Per Business Quant, the three latest NKTR Treasury Shares figures stand at $3.0 million (Q2 2025), $3.0 million (Q1 2025), and $3.0 million (Q4 2024).